{"id":526281,"date":"2018-09-25T14:04:25","date_gmt":"2018-09-25T18:04:25","guid":{"rendered":"https:\/\/www.sciencedaily.com\/releases\/2018\/09\/180925140425.htm"},"modified":"2018-09-25T14:04:25","modified_gmt":"2018-09-25T18:04:25","slug":"lung-cancer-drug-could-be-repurposed-to-target-zombie-proteins-linked-to-leukemia","status":"publish","type":"post","link":"https:\/\/spaceweekly.com\/?p=526281","title":{"rendered":"Lung cancer drug could be repurposed to target &#8216;zombie&#8217; proteins linked to leukemia"},"content":{"rendered":"<p>A new study highlights how a clinically approved lung cancer drug could potentially be &#8216;repurposed&#8217; to design new treatments for future cancer therapies. The research focuses on a protein called TRIB2, which is linked to promoting survival and drug resistance in solid tumors and blood cancers and is therefore of particular interest as a therapeutic target. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>A new study highlights how a clinically approved lung cancer drug could potentially be &#8216;repurposed&#8217; to design new treatments for future cancer therapies. The research focuses on a protein called TRIB2, which is linked to promoting survival and drug res&#8230;<\/p>\n","protected":false},"author":61,"featured_media":615444,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-526281","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/spaceweekly.com\/index.php?rest_route=\/wp\/v2\/posts\/526281","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/spaceweekly.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/spaceweekly.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/spaceweekly.com\/index.php?rest_route=\/wp\/v2\/users\/61"}],"replies":[{"embeddable":true,"href":"https:\/\/spaceweekly.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=526281"}],"version-history":[{"count":1,"href":"https:\/\/spaceweekly.com\/index.php?rest_route=\/wp\/v2\/posts\/526281\/revisions"}],"predecessor-version":[{"id":526282,"href":"https:\/\/spaceweekly.com\/index.php?rest_route=\/wp\/v2\/posts\/526281\/revisions\/526282"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/spaceweekly.com\/index.php?rest_route=\/wp\/v2\/media\/615444"}],"wp:attachment":[{"href":"https:\/\/spaceweekly.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=526281"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/spaceweekly.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=526281"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/spaceweekly.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=526281"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}